← Back to Clinical Trials
Recruiting NCT07493837

NCT07493837 Land- and Water-based Inspiratory Muscle Training in Young Swimmers

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07493837
Status Recruiting
Phase
Sponsor Ondokuz Mayıs University
Condition Sport Performance
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2026-03-01
Primary Completion 2026-05-01

Eligibility & Interventions

Sex All sexes
Min Age 13 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
Land-Based Inspiratory Muscle TrainingSwimming-Based Inspiratory Muscle TrainingWater-Based Static Inspiratory Muscle Training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2026-03-01 with a primary completion date of 2026-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to investigate the effects of four weeks of land- and water-based inspiratory muscle training (IMT) on performance and selected physiological variables in young swimmers. A total of 30 competitive swimmers (22 males and 8 females), who have been training regularly for at least two years, will be voluntarily recruited and assigned to three groups: Land + IMT, Swimming + IMT, and Water + IMT. To compare the effects of different training protocols and evaluate their specific contributions to performance, participants will undergo assessments before the intervention and after the completion of the four-week training period. These assessments will include anthropometric measurements, pulmonary function tests, respiratory muscle strength, 100- and 200-meter freestyle swimming performance, stroke rate and stroke efficiency, as well as cardiopulmonary capacity. Previous studies investigating the effects of inspiratory muscle training in swimmers have generally applied the intervention in land-based settings and reported positive physical and physiological adaptations. However, to the best of our knowledge, no previous study has examined the effects of IMT performed in the water in swimmers. This novel approach is expected to better simulate the actual breathing demands encountered during swimming, thereby improving respiratory control, promoting a more efficient breathing rhythm during competition, and enhancing swimming performance.

Eligibility Criteria

Inclusion Criteria: Young competitive swimmers aged between 13 and 18 years. Regular participation in swimming training for at least 2 years. Participation in routine training consisting of approximately 20 hours/week of pool training and 8 hours/week of land training. Being medically fit to participate in swimming training and inspiratory muscle training. \- Exclusion Criteria: Presence of any acute or chronic respiratory, cardiovascular, neurological, or musculoskeletal disorder that may affect exercise performance or respiratory function. Current upper or lower respiratory tract infection at the time of assessment or intervention. Use of medication that may affect respiratory or exercise performance.

Contact & Investigator

Central Contact

Bilgehan M Çaloğlu, MSc

✉ bilgehanmeliksah99@gmail.com

📞 +905455236037

Principal Investigator

Özgür Bostancı, Prof. Dr.

STUDY DIRECTOR

Ondokuz Mayıs University

Frequently Asked Questions

Who can join the NCT07493837 clinical trial?

This trial is open to participants of all sexes, aged 13 Years or older, up to 18 Years, studying Sport Performance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07493837 currently recruiting?

Yes, NCT07493837 is actively recruiting participants. Contact the research team at bilgehanmeliksah99@gmail.com for enrollment information.

Where is the NCT07493837 trial being conducted?

This trial is being conducted at Samsun, Turkey (Türkiye).

Who is sponsoring the NCT07493837 clinical trial?

NCT07493837 is sponsored by Ondokuz Mayıs University. The principal investigator is Özgür Bostancı, Prof. Dr. at Ondokuz Mayıs University. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology